← All companies
Bristol-Myers Squibb Company
BMY
Market cap$114.08 B
Rank#132
SEC filings1,000
The table below shows Bristol-Myers Squibb Company's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.57B | $15.73B | $12.60B | $10.88B | $7.89B | $6.29B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $7.95B | $9.62B | $9.71B | $9.06B | $9.32B | $9.75B |
| Inventory | $2.76B | $2.76B | $2.74B | $2.67B | $3.33B | $3.08B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.